Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Southern Acids (M) BhdXKLS:5134 67 3-Year EBITDA Growth Rate is 1.40% as of Jun. 2026, which is 63% below its 10-year median of 3.75. GuruFocus rates XKLS:5134 with a GF Score™ of 67/100 and a GF Value™ of RM3.00 (Fairly Valued). The stock has 5 warning signs investors should review. Among 471 Conglomerates companies, Southern Acids (M) Bhd ranks worse than 59.87% on this metric.
During the past 12 months, Southern Acids (M) Bhd's average EBITDA Per Share Growth Rate was 24.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 1.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -2.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 6.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Southern Acids (M) Bhd was 47.40% per year. The lowest was -16.80% per year. And the median was 3.75% per year.
Southern Acids (M) Bhd (XKLS:5134) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Southern Acids (M) Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:5134 vs MMM, HON: 3-Year EBITDA Growth Rate Comparison
For the Conglomerates subindustry, Southern Acids (M) Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd 3-Year EBITDA Growth Rate vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's 3-Year EBITDA Growth Rate falls into.
Southern Acids (M) Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 1.40% mean?
Southern Acids (M) Bhd (XKLS:5134) has a 3-Year EBITDA Growth Rate of 1.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Southern Acids (M) Bhd and its competitors. This is 63% below median its historical median of 3.75. According to the industry distribution chart, Southern Acids (M) Bhd ranks #282 out of 471 companies in the Conglomerates industry, placing it in the top 59.9%.
Is Southern Acids (M) Bhd's 3-Year EBITDA Growth Rate too high?
Southern Acids (M) Bhd's current 3-Year EBITDA Growth Rate of 1.40% is 63% below median its 10-year median of 3.75. The Conglomerates industry median 3-Year EBITDA Growth Rate is 6.90. Southern Acids (M) Bhd's value of 1.40% is 79.7% below this industry median. Based on the distribution chart, Southern Acids (M) Bhd ranks #282 out of 471 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Southern Acids (M) Bhd has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's 3-Year EBITDA Growth Rate compare to MMM and HON?
According to the Conglomerates industry distribution chart, Southern Acids (M) Bhd ranks #282 out of 471 companies for 3-Year EBITDA Growth Rate. This places Southern Acids (M) Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 6.90. Southern Acids (M) Bhd's value of 1.40% is 79.7% below this benchmark. While the company's 10-year median is 3.75 vs. the industry median of 6.90, Southern Acids (M) Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Conglomerates company?
The median 3-Year EBITDA Growth Rate among Conglomerates companies is 6.90, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Southern Acids (M) Bhd's current 3-Year EBITDA Growth Rate of 1.40% is 79.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Southern Acids (M) Bhd and its competitors. For the Conglomerates industry, the median 3-Year EBITDA Growth Rate is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current 3-Year EBITDA Growth Rate is 1.40%, which is 63% below median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM3.00, compared to a current price of RM3.14 — trading 4.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 1.40%, which is 63% below median its 10-year median of 3.75 and 79.7% below the Conglomerates industry median of 6.90. Southern Acids (M) Bhd's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current 3-Year EBITDA Growth Rate is 1.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.14 is trading 4.7% above its estimated GF Value™ of RM3.00.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
3-Year EBITDA Growth Rate: 1.40% (63% below median its 10-year median of 3.75)
GF Value™: RM3.00 vs. price of RM3.14 (4.7% above fair value)
Industry Position: 79.7% below the Conglomerates median (#282 of 471)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
67GF Score
Get the complete analysis for XKLS:5134
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
